Special Feature: Third-Party Releases After The Second Circuit Decision In Purdue Pharma

W
WilmerHale

Contributor

WilmerHale provides legal representation across a comprehensive range of practice areas critical to the success of its clients. With a staunch commitment to public service, the firm is a leader in pro bono representation. WilmerHale is 1,000 lawyers strong with 12 offices in the United States, Europe and Asia.
In an article published by Creditor Rights Coalition, Partner Philip Anker evaluates the Second Circuit's recent decision in Purdue Pharma.
United States Insolvency/Bankruptcy/Re-Structuring
To print this article, all you need is to be registered or login on Mondaq.com.

In an article published by Creditor Rights Coalition, Partner Philip Ankerevaluates the Second Circuit's recent decision in Purdue Pharma.

Excerpt: There are three lenses through which I view the Second Circuit's recent decision in Purdue.

The first is one of policy - if I could amend the Bankruptcy Code, would it permit non-consensual, third-party releases?

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

Special Feature: Third-Party Releases After The Second Circuit Decision In Purdue Pharma

United States Insolvency/Bankruptcy/Re-Structuring

Contributor

WilmerHale provides legal representation across a comprehensive range of practice areas critical to the success of its clients. With a staunch commitment to public service, the firm is a leader in pro bono representation. WilmerHale is 1,000 lawyers strong with 12 offices in the United States, Europe and Asia.
See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More